Example: stock market
EMPEROR-Preserved Trial

EMPEROR-Preserved Trial

Back to document page

EMPEROR-Preserved – Study Design Aim: to evaluate efficacy and safety of empagliflozin versus placebo, on top of standard of care, in patients with HFpEF with or without diabetes Population: T2DM & non-T2DM, aged ≥18 years, chronic HF (NYHA class II–IV), eGFR≥20 EMPEROR-Preserved LVEF >40% 5988 patients Median follow-up = 26 months Placebo once …

  Efficacy

Download EMPEROR-Preserved Trial


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries